<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Everett J</submitter><funding>NCRR NIH HHS</funding><funding>NIMHD NIH HHS</funding><funding>Alzheimer&amp;apos;s Association</funding><funding>University of Warwick</funding><funding>Engineering and Physical Sciences Research Council</funding><funding>University of Texas at San Antonio</funding><pagination>11782-11796</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6034173</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(25)</volume><pubmed_abstract>Altered metabolism of biometals in the brain is a key feature of Alzheimer's disease, and biometal interactions with amyloid-β are linked to amyloid plaque formation. Iron-rich aggregates, including evidence for the mixed-valence iron oxide magnetite, are associated with amyloid plaques. To test the hypothesis that increased chemical reduction of iron, as observed in vitro in the presence of aggregating amyloid-β, may occur at sites of amyloid plaque formation in the human brain, the nanoscale distribution and physicochemical states of biometals, particularly iron, were characterised in isolated amyloid plaque cores from human Alzheimer's disease cases using synchrotron X-ray spectromicroscopy. In situ X-ray magnetic circular dichroism revealed the presence of magnetite: a finding supporte</pubmed_abstract><journal>Nanoscale</journal><pubmed_title>Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.</pubmed_title><pmcid>PMC6034173</pmcid><funding_grant_id>EP/N033191/1- EP/N033140/1</funding_grant_id><funding_grant_id>G12MD007591</funding_grant_id><funding_grant_id>EP/K035193/1</funding_grant_id><funding_grant_id>1745807</funding_grant_id><funding_grant_id>5G12RR013646</funding_grant_id><funding_grant_id>AARFD-17-529742</funding_grant_id><funding_grant_id>EP/N033191/1</funding_grant_id><funding_grant_id>G12 RR013646</funding_grant_id><funding_grant_id>EP/N033140/1</funding_grant_id><funding_grant_id>G12 MD007591</funding_grant_id><pubmed_authors>Everett J</pubmed_authors><pubmed_authors>Lermyte F</pubmed_authors><pubmed_authors>Dobson J</pubmed_authors><pubmed_authors>Perry G</pubmed_authors><pubmed_authors>Tjendana-Tjhin V</pubmed_authors><pubmed_authors>Telling ND</pubmed_authors><pubmed_authors>Hands-Portman I</pubmed_authors><pubmed_authors>Collingwood JF</pubmed_authors><pubmed_authors>Plascencia-Villa G</pubmed_authors><pubmed_authors>Brooks J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects.</name><description>Altered metabolism of biometals in the brain is a key feature of Alzheimer's disease, and biometal interactions with amyloid-β are linked to amyloid plaque formation. Iron-rich aggregates, including evidence for the mixed-valence iron oxide magnetite, are associated with amyloid plaques. To test the hypothesis that increased chemical reduction of iron, as observed in vitro in the presence of aggregating amyloid-β, may occur at sites of amyloid plaque formation in the human brain, the nanoscale distribution and physicochemical states of biometals, particularly iron, were characterised in isolated amyloid plaque cores from human Alzheimer's disease cases using synchrotron X-ray spectromicroscopy. In situ X-ray magnetic circular dichroism revealed the presence of magnetite: a finding supporte</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jul</publication><modification>2026-07-15T19:38:04.725Z</modification><creation>2026-07-09T03:07:38.112Z</creation></dates><accession>S-EPMC6034173</accession><cross_references><pubmed>29688240</pubmed><doi>10.1039/c7nr06794a</doi></cross_references></HashMap>